BPK3079 Citations (5)

Originally described in: Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Kleinstiver BP, Tsai SQ, Prew MS, Nguyen NT, Welch MM, Lopez JM, McCaw ZR, Aryee MJ, Joung JK Nat Biotechnol. 2016 Jun 27. doi: 10.1038/nbt.3620. PubMed Journal

---

Articles Citing BPK3079

Articles
Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric Liver. Tsukamoto T, Sakai E, Iizuka S, Taracena-Gandara M, Sakurai F, Mizuguchi H. Biol Pharm Bull. 2018;41(7):1089-1095. doi: 10.1248/bpb.b18-00222. PubMed
Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA. Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15. PubMed
Controlling Gene Expression in Mammalian Cells Using Multiplexed Conditional Guide RNAs for Cas12a*. Oesinghaus L, Simmel FC. Angew Chem Int Ed Engl. 2021 Oct 25;60(44):23894-23902. doi: 10.1002/anie.202107258. Epub 2021 Sep 29. PubMed
A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation. Wang X, Dong K, Kong D, Zhou Y, Yin J, Cai F, Wang M, Ye H. Sci Adv. 2021 Dec 10;7(50):eabh2358. doi: 10.1126/sciadv.abh2358. Epub 2021 Dec 10. PubMed
Blocking YAP1-Liprin-beta2 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma. Woo SR, Noh JK, Lee MK, Kong M, Min S, Sung JY, Na K, Kang S, Hur JK, Ko SG, Eun YG. Sci Rep. 2025 Jul 24;15(1):26968. doi: 10.1038/s41598-025-11652-0. PubMed

If you have published an article using this material, please email us at to have your article added to this page.